M. Boggild

1.5k total citations
24 papers, 1.1k citations indexed

About

M. Boggild is a scholar working on Pathology and Forensic Medicine, Rheumatology and Immunology. According to data from OpenAlex, M. Boggild has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 6 papers in Rheumatology and 5 papers in Immunology. Recurrent topics in M. Boggild's work include Multiple Sclerosis Research Studies (15 papers), Systemic Lupus Erythematosus Research (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). M. Boggild is often cited by papers focused on Multiple Sclerosis Research Studies (15 papers), Systemic Lupus Erythematosus Research (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). M. Boggild collaborates with scholars based in United Kingdom, United States and Australia. M. Boggild's co-authors include Anthony A. Fryer, Carolyn Young, Per Soelberg Sørensen, Xavier Montalbán, Johann Sellner, Michel Clanet, Renaud Du Pasquier, Zsolt Illés, Bernhard Hemmer and Chris H. Polman and has published in prestigious journals such as Brain, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

M. Boggild

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Boggild United Kingdom 15 753 323 222 206 184 24 1.1k
P. O’Connor Canada 10 783 1.0× 221 0.7× 152 0.7× 233 1.1× 120 0.7× 16 1.0k
Mikaël Cohen France 19 750 1.0× 493 1.5× 262 1.2× 109 0.5× 241 1.3× 95 1.3k
Nebojša Stojsavljević Serbia 19 702 0.9× 218 0.7× 257 1.2× 176 0.9× 136 0.7× 34 1.0k
Filipe Palavra Portugal 12 592 0.8× 235 0.7× 196 0.9× 85 0.4× 147 0.8× 44 921
E. Verdun Italy 14 843 1.1× 437 1.4× 379 1.7× 148 0.7× 64 0.3× 25 1.1k
Mark Rametta United States 10 530 0.7× 127 0.4× 146 0.7× 168 0.8× 76 0.4× 19 700
Marja‐Liisa Sumelahti Finland 16 653 0.9× 125 0.4× 145 0.7× 179 0.9× 114 0.6× 45 911
Agnès Fromont France 11 430 0.6× 194 0.6× 143 0.6× 85 0.4× 91 0.5× 30 809
Rachel Farrell United Kingdom 14 359 0.5× 136 0.4× 143 0.6× 160 0.8× 131 0.7× 44 755
Dian He China 16 363 0.5× 224 0.7× 69 0.3× 85 0.4× 146 0.8× 49 669

Countries citing papers authored by M. Boggild

Since Specialization
Citations

This map shows the geographic impact of M. Boggild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Boggild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Boggild more than expected).

Fields of papers citing papers by M. Boggild

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Boggild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Boggild. The network helps show where M. Boggild may publish in the future.

Co-authorship network of co-authors of M. Boggild

This figure shows the co-authorship network connecting the top 25 collaborators of M. Boggild. A scholar is included among the top collaborators of M. Boggild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Boggild. M. Boggild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huda, Saif, et al.. (2016). Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disability. Journal of the Neurological Sciences. 362. 66–68. 10 indexed citations
2.
Simpson, Steve, et al.. (2015). The epidemiology of multiple sclerosis in the Isle of Man: 2006-2011. Acta Neurologica Scandinavica. 132(6). 381–388. 7 indexed citations
3.
Bregenzer, Thomas, Helen Tremlett, Martin Duddy, et al.. (2013). Modelling natural history for the UK multiple sclerosis risk-sharing scheme. Multiple Sclerosis Journal. 19. 339–339. 3 indexed citations
4.
George, Jithin, J Kitley, Maria Isabel Leite, et al.. (2012). 133 Aquaporin 4 antibody seropositivity and visual function in a UK cohort. Journal of Neurology Neurosurgery & Psychiatry. 83(3). e1.85–e1. 1 indexed citations
5.
Sellner, Johann, M. Boggild, Michel Clanet, et al.. (2010). EFNS guidelines on diagnosis and management of neuromyelitis optica. European Journal of Neurology. 17(8). 1019–1032. 330 indexed citations
6.
Scolding, Neil, et al.. (2010). A window of opportunity for no treatment in early multiple sclerosis?. Multiple Sclerosis Journal. 16(6). 756–759. 9 indexed citations
7.
Boggild, M., et al.. (2010). PAW25 A single-centre, pilot, randomised controlled trial of recombinant human erythropoietin in primary progressive multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 81(11). e30–e30. 5 indexed citations
8.
Boggild, M., Jacqueline Palace, Pelham Barton, et al.. (2009). Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator. BMJ. 339(dec02 1). b4677–b4677. 67 indexed citations
9.
Ellis, Richard & M. Boggild. (2009). Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?. Multiple Sclerosis Journal. 15(4). 505–508. 63 indexed citations
10.
Woolmore, John, M. Boggild, Carolyn Young, et al.. (2008). Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis. Multiple Sclerosis Journal. 14(9). 1280–1283. 33 indexed citations
11.
Woolmore, John, M. Boggild, Carolyn Young, et al.. (2007). Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation. Multiple Sclerosis Journal. 13(3). 369–375. 26 indexed citations
12.
Thain, J., et al.. (2006). A randomized controlled trial of a health promotion education programme for people with multiple sclerosis. Clinical Rehabilitation. 20(9). 783–792. 69 indexed citations
13.
Davies, M. B., V L Stevenson, Siobhan M Leary, et al.. (2002). Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. Journal of Neuroimmunology. 129(1-2). 197–204. 48 indexed citations
14.
Boggild, M., et al.. (2002). Comparison of Standard Care Against Rehabilitation in Steroid Treatment for Multilple Sclerosis Relapse. Physiotherapy. 88(1). 56–56. 1 indexed citations
15.
Weatherby, S. J. M., Wendy Thomson, L Pepper, et al.. (2001). HLA-DRB1 and disease outcome in multiple sclerosis. Journal of Neurology. 248(4). 304–310. 53 indexed citations
16.
Davies, M. B., M. Boggild, Julie Alldersea, et al.. (2000). Glutathione S-transferase polymorphisms in MS. Neurology. 54(3). 552–552. 76 indexed citations
17.
Weatherby, S. J. M., M. B. Davies, D Carthy, et al.. (2000). Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis. Multiple Sclerosis Journal. 6(1). 32–36. 50 indexed citations
18.
Pickard, C., P. J. Sinnott, M. Boggild, et al.. (1999). Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis. Journal of Neuroimmunology. 101(2). 207–210. 32 indexed citations
19.
Fryer, Anthony A., Lei Zhao, Julie Alldersea, et al.. (1993). The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas. Carcinogenesis. 14(4). 563–566. 45 indexed citations
20.
Boggild, M.. (1992). Intracerebral haemorrhage after dermal nitrate application.. BMJ. 305(6860). 1000.3–1000. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. O’Connor Breakdown of academic impact, for papers by Mikaël Cohen Breakdown of academic impact, for papers by Nebojša Stojsavljević Breakdown of academic impact, for papers by Filipe Palavra Breakdown of academic impact, for papers by E. Verdun Breakdown of academic impact, for papers by Mark Rametta Breakdown of academic impact, for papers by Marja‐Liisa Sumelahti Breakdown of academic impact, for papers by Agnès Fromont Breakdown of academic impact, for papers by Rachel Farrell Breakdown of academic impact, for papers by Dian He
Rankless by CCL
2026